Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Olivia Koenig"'
Autor:
Olivia Koenig, Dimitrios Nothdurft, Nadja Perle, Bernd Neumann, Andreas Behring, Ilka Degenkolbe, Tobias Walker, Christian Schlensak, Hans Peter Wendel, Andrea Nolte
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 6, Iss , Pp 290-301 (2017)
In the last decades, many efforts have been made to counteract adverse effects after stenting atherosclerotic coronary arteries. A breakthrough in better vascular wall regeneration was noted in the new era of drug-eluting stents. A novel personalized
Externí odkaz:
https://doaj.org/article/3ca6e86c2f344264a05f79ac20edd4e4
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0212584 (2019)
Local gene delivery systems utilizing RNA interference technology are a promising approach for therapeutic applications where site-specific release of agents is desired. Polyelectrolyte multilayers (PEMs) can be constructed using the layer-by-layer (
Externí odkaz:
https://doaj.org/article/5b9292b733b84282b985abe7df0bad6f
Autor:
Hans-Peter Wendel, Bernd Neumann, Christian Schlensak, Almuth Zech, Nadja Perle, Olivia Koenig, Tobias Walker, Andrea Nolte
Publikováno v:
Pharmaceuticals, Vol 6, Iss 7, Pp 881-914 (2013)
Coronary heart disease (CHD), mainly caused by atherosclerosis, represents the single leading cause of death in industrialized countries. Besides the classical interventional therapies new applications for treatment of vascular wall pathologies are a
Externí odkaz:
https://doaj.org/article/1c2a8130b6c74c8a94f8a7c09ef7098b
Autor:
Olivia Koenig, Diane Zengerle, Nadja Perle, Susanne Hossfeld, Bernd Neumann, Andreas Behring, Meltem Avci-Adali, Tobias Walker, Christian Schlensak, Hans Peter Wendel, Andrea Nolte
Publikováno v:
Pharmaceuticals, Vol 10, Iss 1, p 23 (2017)
Presently, a new era of drug-eluting stents is continuing to improve late adverse effects such as thrombosis after coronary stent implantation in atherosclerotic vessels. The application of gene expression–modulating stents releasing specific small
Externí odkaz:
https://doaj.org/article/239060b310d8499897d444e8287749af
Autor:
Hans Peter Wendel, Tobias Walker, Olivia Koenig, Dimitrios Nothdurft, Andreas Behring, Ilka Degenkolbe, Nadja Perle, Bernd Neumann, Christian Schlensak, Andrea Nolte
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 6, Iss, Pp 290-301 (2017)
Molecular Therapy: Nucleic Acids, Vol 6, Iss, Pp 290-301 (2017)
In the last decades, many efforts have been made to counteract adverse effects after stenting atherosclerotic coronary arteries. A breakthrough in better vascular wall regeneration was noted in the new era of drug-eluting stents. A novel personalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e425d681db5668bc72b69e3e6704f02
http://europepmc.org/articles/PMC5363512
http://europepmc.org/articles/PMC5363512
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0212584 (2019)
PLoS ONE
PLoS ONE
Local gene delivery systems utilizing RNA interference technology are a promising approach for therapeutic applications where site-specific release of agents is desired. Polyelectrolyte multilayers (PEMs) can be constructed using the layer-by-layer (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9db68f98068847239991ecd2a8a35a
https://doaj.org/article/5b9292b733b84282b985abe7df0bad6f
https://doaj.org/article/5b9292b733b84282b985abe7df0bad6f
Autor:
Christian Schlensak, Meltem Avci-Adali, Tobias Walker, Bernd Neumann, Diane Zengerle, Nadja Perle, Andreas Behring, Hans Peter Wendel, Andrea Nolte, Olivia Koenig, Susanne Hossfeld
Publikováno v:
Pharmaceuticals
Pharmaceuticals; Volume 10; Issue 1; Pages: 23
Pharmaceuticals, Vol 10, Iss 1, p 23 (2017)
Pharmaceuticals; Volume 10; Issue 1; Pages: 23
Pharmaceuticals, Vol 10, Iss 1, p 23 (2017)
Presently, a new era of drug-eluting stents is continuing to improve late adverse effects such as thrombosis after coronary stent implantation in atherosclerotic vessels. The application of gene expression–modulating stents releasing specific small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e32f6f60764a970ff0839b2ae538ff
https://doi.org/10.3390/ph10010023
https://doi.org/10.3390/ph10010023
Autor:
Almuth Zech, Tobias Walker, Olivia Koenig, Hans Peter Wendel, Christian Schlensak, Bernd Neumann, Nadja Perle, Andrea Nolte
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 6, Iss 7, Pp 881-914 (2013)
Pharmaceuticals, Vol 6, Iss 7, Pp 881-914 (2013)
Coronary heart disease (CHD), mainly caused by atherosclerosis, represents the single leading cause of death in industrialized countries. Besides the classical interventional therapies new applications for treatment of vascular wall pathologies are a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d178a6efa7d4ff5df70035cafe249b7
https://pubmed.ncbi.nlm.nih.gov/24276320
https://pubmed.ncbi.nlm.nih.gov/24276320